zanamivir has been researched along with tamiflu in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kakuta, M; Kubo, S; Tokumitsu, A; Tomozawa, T; Yamashita, M | 1 |
| Feng, E; Jiang, H; Li, J; Liu, H; Liu, X; No, KT; Seong, BL; Shin, WJ; Tang, W; Wang, J; Ye, D; Zheng, M; Zhu, W; Zhu, X; Zuo, JP | 1 |
| Abdel-Mageed, WM; Bayoumi, SA; Chen, C; Dai, H; Gao, GF; Li, L; Liu, L; Liu, X; Lv, Y; Malik, A; Sayed, HM; Song, F; Vavricka, CJ; Wang, L; Zhang, J; Zhang, L | 1 |
3 other study(ies) available for zanamivir and tamiflu
| Article | Year |
|---|---|
Laninamivir prodrug CS-8958, a long-acting neuraminidase inhibitor, shows superior anti-influenza virus activity after a single administration.
Topics: Animals; Antiviral Agents; Disease Models, Animal; Ferrets; Humans; Influenza A Virus, H1N1 Subtype; Influenza B virus; Mice; Mice, Inbred BALB C; Neuraminidase; Orthomyxoviridae Infections; Oseltamivir; Prodrugs; Treatment Outcome; Zanamivir | 2010 |
Structure-based design and synthesis of C-1- and C-4-modified analogs of zanamivir as neuraminidase inhibitors.
Topics: Antiviral Agents; Drug Design; Enzyme Inhibitors; Models, Molecular; Neuraminidase; Zanamivir | 2013 |
Benzophenone C-glucosides and gallotannins from mango tree stem bark with broad-spectrum anti-viral activity.
Topics: 3C Viral Proteases; Antineoplastic Agents, Phytogenic; Antiviral Agents; Benzophenones; Cell Proliferation; Cysteine Endopeptidases; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Enterovirus B, Human; HeLa Cells; Hep G2 Cells; Humans; Hydrolyzable Tannins; Influenza A virus; Mangifera; Molecular Structure; Plant Bark; Plant Stems; Protease Inhibitors; Structure-Activity Relationship; Tumor Cells, Cultured; Viral Proteins | 2014 |